Fri, Nov 13, 2026 - Page 27
7377 indexed SquawkNews stories from this UTC day. Showing 3121-3240.
L
US Treasury Secretary Bessent: Did Nvidia know its clients, and did it aim to stop leaks? $NVDA
US Treasury Secretary Bessent: Did Nvidia know its clients, and did it aim to stop leaks? $NVDA
NEWS | Nov 13, 2026, 01:07 PM UTC
L
Randoncorp Q3 2026 Net Income Falls 17% Year Over Year to R$ 19.24 Million
Randoncorp Q3 2026 Net Income Falls 17% Year Over Year to R$ 19.24 Million Randoncorp’s third-qu
EQUITY | Nov 13, 2026, 01:07 PM UTC
L
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth
WOBURN, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. NASDAQ:BFRI ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (P
EARNINGS | Nov 13, 2026, 01:07 PM UTC
H
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
Ended third quarter with $24.1 million in cash and restricted cash- Expects positive fourth quarter earnings between $0.01 and $0.04 per shareTARPON SPRINGS, Fla., November 13, 2026 — Allarity Therapeutics, Inc. (“Allari
EARNINGS | Nov 13, 2026, 01:07 PM UTC
L
Allarity Therapeutics 3Q Loss $6.2M >ALLR
Allarity Therapeutics 3Q Loss $6.2M >ALLR
EQUITY | Nov 13, 2026, 01:07 PM UTC
H
HOVE A/S - UPDATED GUIDANCE DOES NOT REFLECT MATERIAL CHANGE IN COMPANY'S UNDERLYING BUSINESS
HOVE A/S - UPDATED GUIDANCE DOES NOT REFLECT MATERIAL CHANGE IN COMPANY'S UNDERLYING BUSINESS
EARNINGS | Nov 13, 2026, 01:07 PM UTC
H
ALLARITY THERAPEUTICS: EXPECTS POSITIVE Q4 EARNINGS BETWEEN $0.01 AND $0.04 PER SHARE
ALLARITY THERAPEUTICS: EXPECTS POSITIVE Q4 EARNINGS BETWEEN $0.01 AND $0.04 PER SHARE
EARNINGS | Nov 13, 2026, 01:07 PM UTC
L
GH RESEARCH PLC Q3 EPS USD -0.18
GH RESEARCH PLC Q3 EPS USD -0.18
EARNINGS | Nov 13, 2026, 01:07 PM UTC
L
Arrive AI Reports Third Quarter 2026 Results Highlighted by Revenue Growth and Expanded Partnerships
Arrive AI Reports Third Quarter 2026 Results Highlighted by Revenue Growth and Expanded Partnerships
EARNINGS | Nov 13, 2026, 01:07 PM UTC
L
ARRIVE AI Q3 NET INCOME USD -3.7 MILLION
ARRIVE AI Q3 NET INCOME USD -3.7 MILLION
FX | Nov 13, 2026, 01:07 PM UTC
H
Allarity Therapeutics (ALLR) Expects Q4 EPS of $0.01—$0.04
Allarity ended Q3 with $24.1M in cash and restricted cash and expects Q4 earnings of $0.01—$0.04 per share. The release attributes the expected Q4 earnings primarily to a gain from settling a legacy liability.Material De
EARNINGS | Nov 13, 2026, 01:07 PM UTC
L
SUNCRETE - 2026 REVENUE OUTLOOK $408 MLN-$434 MLN
SUNCRETE - 2026 REVENUE OUTLOOK $408 MLN-$434 MLN
EARNINGS | Nov 13, 2026, 01:06 PM UTC
L
Bessent Says US Is Working to Curb Chip Export-Control Leakage
Bessent said there is significant leakage in the chip export system and that officials are working to address it.
REGULATION | Nov 13, 2026, 01:06 PM UTC
L
Allarity Therapeutics Sees 4Q EPS 1c-EPS 4c >ALLR
Allarity Therapeutics Sees 4Q EPS 1c-EPS 4c >ALLR
EARNINGS | Nov 13, 2026, 01:06 PM UTC
H
HOVE NARROWS 2026 EBITDA GUIDANCE TO DKK 23-25 MILLION
HOVE NARROWS 2026 EBITDA GUIDANCE TO DKK 23-25 MILLION
EARNINGS | Nov 13, 2026, 01:06 PM UTC
L
US Trsy Sec Bessent On Entity List: Treasury Was In Favor Of Putting Megaspeed On For Months - CNBC Interview
Commerce Did Not Add Megaspeed To Export Control List - Any Leak Of Advanced Chips Very Frustrating - Commerce Dept Needs To Be Asked About Blacklisting - Treasury Has Been Pushing For Export Controls - It Was Clear Chin
GEOPOLITICS | Nov 13, 2026, 01:06 PM UTC
M
Lowe’s shares fall about 2% premarket after Stifel downgrade
Stifel downgraded Lowe’s to Sell from Hold.
EQUITY | Nov 13, 2026, 01:06 PM UTC
L
IRulya Therapeutics 3Q Loss/Shr $2.31 >IRLA
IRulya Therapeutics 3Q Loss/Shr $2.31 >IRLA
EQUITY | Nov 13, 2026, 01:06 PM UTC
L
Moving iMage Q1 revenue rises 9% on increased project activity
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EARNINGS | Nov 13, 2026, 01:06 PM UTC
L
Revvity to Showcase Strategy at 2026 Investor Day
Revvity will present its strategy under the theme “Powering Scientific Intelligence” at its 2026 Investor Day.
EQUITY | Nov 13, 2026, 01:06 PM UTC
L
Moving iMage Q1 revenue rises 9% on increased project activity
Moving iMage Q1 revenue rises 9% on increased project activity Overview US cinema technology provide
EARNINGS | Nov 13, 2026, 01:05 PM UTC
L
Allarity Therapeutics Q3 2026 net loss more than doubles to $6.2 million
Allarity Therapeutics Q3 2026 net loss more than doubles to $6.2 million Allarity Therapeutics’
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
Coca-Cola Brings Back Canada's Kindest Community Initiative
Coca-Cola Canada is reopening its community-nomination initiative, with a public vote to select a recipient for a $100,000 donation.
EQUITY | Nov 13, 2026, 01:05 PM UTC
M
Ukraine Says It Hit Major Russian Refinery in Volgograd
Ukraine said it struck one of Russia’s largest refineries in Volgograd, according to Reuters.
ENERGY | Nov 13, 2026, 01:05 PM UTC
L
Bragg Gaming Q3 net loss widens 86% to EUR 4.29 million
Bragg Gaming Q3 net loss widens 86% to EUR 4.29 million Bragg Gaming Group’s third-quarter 2026
FX | Nov 13, 2026, 01:05 PM UTC
L
HealthWarehouse.com (HEWA) Q3 Sales Fell 23% to $6.5M
HealthWarehouse.com reported Q3 2026 net sales of $6.5M, down 23% year over year, and a net loss of $240K versus $72K a year earlier. Adjusted EBITDA was $123K versus $384K.Material DetailsContext by AI AnalystThis is a
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
Nokia Federal Solutions Wins Department of War Drone-Detection Contract
Nokia Federal Solutions won a Department of War contract for drone threat detection.
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
US Treasury Secretary Bessent on export controls: Treasury has been pushing for it.
US Treasury Secretary Bessent on export controls: Treasury has been pushing for it.
NEWS | Nov 13, 2026, 01:05 PM UTC
L
US Treasury Secretary Bessent: It was clear China shouldn't get any chips above H100s
US Treasury Secretary Bessent: It was clear China shouldn't get any chips above H100s
GEOPOLITICS | Nov 13, 2026, 01:05 PM UTC
L
ANNOVIS BIO Q3 EPS USD -0.22
ANNOVIS BIO Q3 EPS USD -0.22
EARNINGS | Nov 13, 2026, 01:05 PM UTC
L
HealthWarehouse.com Reports Results for Third Quarter 2026
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the third quarter ended September 30, 2026, totaled $6.51 million, a 23% decrease from the quarter ended September 30, 2025. In the first half
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
Aardvark Therapeutics 3Q Loss/Shr 88c >AARD
Aardvark Therapeutics 3Q Loss/Shr 88c >AARD
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
HealthWarehouse.com Reports Results for Third Quarter 2026
Positive EBITDA Highlights Operational Strength and Team Execution CINCINNATI--(BUSINESS WIRE)-- Hea
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
US Treasury Secretary Bessent: Commerce department needs to be asked about blacklisting
US Treasury Secretary Bessent: Commerce department needs to be asked about blacklisting
NEWS | Nov 13, 2026, 01:05 PM UTC
L
Coca-Cola Brings Back Canada’s Kindest Community Program
A public vote will let Canadians choose which community receives a $100,000 donation.
EQUITY | Nov 13, 2026, 01:05 PM UTC
H
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
Ended third quarter with $24.1 million in cash and restricted cash - Expects positive fourth quart
EARNINGS | Nov 13, 2026, 01:05 PM UTC
L
ALLARITY THERAPEUTICS Q3 OPERATING INCOME USD -5.507 MILLION
ALLARITY THERAPEUTICS Q3 OPERATING INCOME USD -5.507 MILLION
FX | Nov 13, 2026, 01:05 PM UTC
L
ALLARITY THERAPEUTICS Q3 NET INCOME USD -6.2 MILLION
ALLARITY THERAPEUTICS Q3 NET INCOME USD -6.2 MILLION
FX | Nov 13, 2026, 01:05 PM UTC
H
ALLARITY THERAPEUTICS REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES FULL YEAR 2026 FINANCIAL GUIDANCE
ALLARITY THERAPEUTICS REPORTS THIRD QUARTER 2026 RESULTS AND PROVIDES FULL YEAR 2026 FINANCIAL GUIDA
EARNINGS | Nov 13, 2026, 01:05 PM UTC
L
HEALTHWAREHOUSE.COM REPORTS RESULTS FOR THIRD QUARTER 2026
HEALTHWAREHOUSE.COM REPORTS RESULTS FOR THIRD QUARTER 2026
EQUITY | Nov 13, 2026, 01:05 PM UTC
H
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guida
EARNINGS | Nov 13, 2026, 01:05 PM UTC
L
HEALTHWAREHOUSE.COM Q3 SALES USD 6.51 MILLION
HEALTHWAREHOUSE.COM Q3 SALES USD 6.51 MILLION
FX | Nov 13, 2026, 01:05 PM UTC
L
Biofrontera 3Q Loss $6.4M >BFRI
Biofrontera 3Q Loss $6.4M >BFRI
EQUITY | Nov 13, 2026, 01:05 PM UTC
L
Goldman Strategist Sees Slower S&P 500 Earnings Growth, Solid Gains
Goldman Sachs strategist Peter Oppenheimer expects S&P 500 earnings growth to slow notably next year but still sees stocks gaining over the next 12 months, citing lower crude prices, moderating inflation and Treasury yie
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
Bessent Says Treasury Pushed to Add Megaspeed to Entity List
Bessent said Treasury has been pushing for months to add Megaspeed to the entity list.
REGULATION | Nov 13, 2026, 01:04 PM UTC
L
Biofrontera 3Q Loss/Shr 42c >BFRI
Biofrontera 3Q Loss/Shr 42c >BFRI
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
BRAGG GAMING Q3 EPS EUR -0.15
BRAGG GAMING Q3 EPS EUR -0.15
EARNINGS | Nov 13, 2026, 01:04 PM UTC
L
Annovis Bio Q3 net loss widens 30% to $9.46 million
Annovis Bio Q3 net loss widens 30% to $9.46 million Annovis Bio’s third-quarter 2026 net loss wi
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
Suncrete Sees 2026 Adjusted EBITDA $60M-$64M >RMIX
Suncrete Sees 2026 Adjusted EBITDA $60M-$64M >RMIX
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
Biofrontera Q3 net loss narrows to $6.42 million; Q3 net product revenue rises 30% to $9.07 million
Biofrontera Q3 net loss narrows to $6.42 million; Q3 net product revenue rises 30% to $9.07 million
EARNINGS | Nov 13, 2026, 01:04 PM UTC
M
Nakamoto Shares Fall 6% Premarket After Q3 Revenue Turns Negative
Nakamoto shares fell 6.5% in premarket trading after Bitcoin-options losses pushed third-quarter operating revenue below zero. The stock traded at $5.40 at 12:02 p.m. UTC Friday.
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
Eagle Point Income 3Q EPS 20c >EIC
Eagle Point Income 3Q EPS 20c >EIC
EARNINGS | Nov 13, 2026, 01:04 PM UTC
L
Singapore's Frasers Property full-year revenue rises 6.8%
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 13, 2026, 01:04 PM UTC
L
Benitec Biopharma 1Q Loss/Shr 26c >BNTC
Benitec Biopharma 1Q Loss/Shr 26c >BNTC
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
Russia Says Europeans Can Join Ukraine Peace Talks if Ready to Contribute
Russia said European countries can join talks on Ukraine if they show readiness to contribute.
GEOPOLITICS | Nov 13, 2026, 01:04 PM UTC
L
Benitec Biopharma 1Q Loss $12.9M >BNTC
Benitec Biopharma 1Q Loss $12.9M >BNTC
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
BRIEF-Biofrontera Q3 Revenue USD 9.1 Million
Nov 13 (Reuters) - Biofrontera Q3 adjusted EBITDA USD -5.5 million.
EARNINGS | Nov 13, 2026, 01:04 PM UTC
L
Smartbird Publishes CEO Shareholder Letter
Smartbird published a shareholder letter from CEO Nadia Carlsten. The body says Smartbird secured a US data center, but provides no further details.
EQUITY | Nov 13, 2026, 01:04 PM UTC
L
US Treasury Secretary Bessent: Any leak of advanced chips is very frustrating
US Treasury Secretary Bessent: Any leak of advanced chips is very frustrating
NEWS | Nov 13, 2026, 01:03 PM UTC
L
Singapore's Frasers Property full-year revenue rises 6.8%
Singapore's Frasers Property full-year revenue rises 6.8% Overview Singapore property developer's fu
EARNINGS | Nov 13, 2026, 01:03 PM UTC
L
BRIEF-Biofrontera Q3 Revenue USD 9.1 Million
BRIEF-Biofrontera Q3 Revenue USD 9.1 Million Nov 13 (Reuters) - Biofrontera Q3 adjusted EBITDA USD
EARNINGS | Nov 13, 2026, 01:03 PM UTC
L
Immunic Reports Q3 2026 Results; Cash of $132 Million
Immunic reported a third-quarter 2026 net loss of $42.3 million, or $0.99 per share, compared with a $25.6 million loss a year earlier. Operating expenses were $43.4 million, and cash and cash equivalents totaled $132.0
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
Bessent Says Commerce Did Not Add Megaspeed to Export Control List
REGULATION | Nov 13, 2026, 01:03 PM UTC
L
GH Research 3Q Loss/Shr 18c >GHRS
GH Research 3Q Loss/Shr 18c >GHRS
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
GH Research 3Q Loss $12.5M >GHRS
GH Research 3Q Loss $12.5M >GHRS
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
Aveanna Reports Q3 2026 Revenue Growth of 11.8% and Adjusted EBITDA Growth of 25%
Aveanna reported Q3 2026 revenue of $695.5 million, up 11.8%, and Adjusted EBITDA of $100.1 million, up 25% year over year.Key Highlights:Original SEC Filing: Aveanna Healthcare Holdings, Inc. [ AVAH ] - 8-K - Nov. 13, 2
EARNINGS | Nov 13, 2026, 01:03 PM UTC
L
Banca Akros and Equita Raise ENAV Price Targets
Banca Akros raised its ENAV target to €4.5 from €4.2, keeping a neutral rating. Equita Sim raised its target to €4.0 from €3.9, maintaining a hold rating. Both noted the company’s third-quarter results were in line with
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
Canlan Sports Q3 net loss narrows 58% to $1.04 million
Canlan Sports Q3 net loss narrows 58% to $1.04 million Canlan Sports’ Q3 2026 net loss narrowed
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
BIOFRONTERA Q3 EPS USD -0.42
BIOFRONTERA Q3 EPS USD -0.42
EARNINGS | Nov 13, 2026, 01:03 PM UTC
L
GH Research Q3 2026 net loss narrows 11% to $12.45 million
GH Research Q3 2026 net loss narrows 11% to $12.45 million GH Research’s third-quarter 2026 net
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
Bragg Gaming 3Q Loss/Shr EUR0.15 >BRAG
Bragg Gaming 3Q Loss/Shr EUR0.15 >BRAG
EQUITY | Nov 13, 2026, 01:03 PM UTC
L
Bessent Says Treasury Favored Adding Megaspeed to Entity List
Bessent said Treasury had favored putting Megaspeed on the entity list for months.
REGULATION | Nov 13, 2026, 01:03 PM UTC
L
US Equity Funds Attract Inflows for Second Straight Week
US equity funds recorded inflows for a second consecutive week, according to a Reuters graphic.
EQUITY | Nov 13, 2026, 01:02 PM UTC
M
ProVen VCT Recommends Merger and Opens Offer for Up to £40M
ProVen VCT recommends merging with ProVen Growth and Income VCT, subject to shareholder approval. Its subscription offer seeks up to £30 million, plus an over-allotment facility of up to £10 million, and is not condition
MNA | Nov 13, 2026, 01:02 PM UTC
M
US Equity Funds Attract Inflows for Second Straight Week
US equity funds drew a net $6.6 billion in the seven days to November 11, about 56% less than the prior week. The report attributed the inflows to CoreWeave's outlook easing concerns about debt-funded technology spending
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
BIOFRONTERA Q3 ADJUSTED EBITDA USD -5.5 MILLION
BIOFRONTERA Q3 ADJUSTED EBITDA USD -5.5 MILLION
FX | Nov 13, 2026, 01:02 PM UTC
L
PAVmed Q3 2026 Net Loss More Than Doubles to $13.04 Million
PAVmed Q3 2026 Net Loss More Than Doubles to $13.04 Million PAVmed's preliminary third-quarter 2
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
BIOFRONTERA Q3 REVENUE USD 9.1 MILLION
BIOFRONTERA Q3 REVENUE USD 9.1 MILLION
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Re
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
BIOFRONTERA INC. REPORTS STRONG THIRD QUARTER 2026 FINANCIAL RESULTS DRIVEN BY 30% YEAR-OVER-YEAR REVENUE GROWTH
BIOFRONTERA INC. REPORTS STRONG THIRD QUARTER 2026 FINANCIAL RESULTS DRIVEN BY 30% YEAR-OVER-YEAR RE
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
BIOFRONTERA Q3 NET INCOME USD -6.4 MILLION
BIOFRONTERA Q3 NET INCOME USD -6.4 MILLION
FX | Nov 13, 2026, 01:02 PM UTC
L
Bragg Gaming 3Q Rev EUR20.6M >BRAG
Bragg Gaming 3Q Rev EUR20.6M >BRAG
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
PDS Biotech Reports Third Quarter 2026 Financial Results
PRINCETON, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation NASDAQ:PDSB (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company focused on transforming how the immune system targets
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Name changed from Quince Therapeutics, Inc. to IRulya Therapeutics Inc.; common stock began trading on the Nasdaq Capital Market under the ticker “IRLA” on October 12, 2026Phase 2 data in bronchiolitis obliterans syndrom
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
BRIEF-Owlet Q3 Adjusted EPS USD 0.11
Nov 13 (Reuters) - Owlet Q3 revenue USD 30.4 million vs. IBES estimate USD 30 million.
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
IRulya Therapeutics Names Brigette Roberts CEO
IRulya Therapeutics appointed Brigette Roberts as CEO.
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Annovis Bio 3Q Loss $9.46M >ANVS
Annovis Bio 3Q Loss $9.46M >ANVS
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Annovis Bio 3Q Loss/Shr 22c >ANVS
Annovis Bio 3Q Loss/Shr 22c >ANVS
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
BRIEF-Bragg Gaming Q3 Revenue EUR 20.6 Million
Nov 13 (Reuters) - Bragg Gaming Q3 gross margin 56%.
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
FDA lifted clinical hold on ARD-101 for the treatment of hyperphagia in Prader-Willi Syndrome (PWS)Meeting with the FDA scheduled for the first quarter of 2027 to discuss the Company’s proposed clinical development plan
REGULATION | Nov 13, 2026, 01:02 PM UTC
L
Eagle Point Credit 3Q Net Investment Income of 31c >ECC
Eagle Point Credit 3Q Net Investment Income of 31c >ECC
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Fortress Biotech Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Total net revenue increased approximately 9% to $19.2 million for the third quarter of 2026 compared to the third quarter of 2025Fortress repaid its credit facility in full in September 2026A subsidiary of Fortress enter
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
Aardvark Therapeutics appoints David Zhang as independent director
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Samsung Electronics to Host Investor Forum in Singapore on November 18
The forum will cover the company’s business vision and technology strategy across its DS, Foundry, Memory and DX divisions, with a focus on AI. Samsung says it will provide no financial guidance or metrics.
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
BIO-key International, Inc. (BKYI) Q3 License Fees Rose 39%; Revenue Fell 4%
Q3 revenue fell 4% to $1.5M from $1.5M a year earlier, while license fees rose 39% to $1.3M. Gross margin rose to 90% from 77%; net loss narrowed to $886K from $965K.Material DetailsContext by AI AnalystThis is an operat
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
Owlet Q3 net income falls 67% to $1.4 million
Owlet Q3 net income falls 67% to $1.4 million Owlet's third-quarter 2026 net income fell 67% yea
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Annovis Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
MALVERN, Pa., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. NYSE:ANVS (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing buntanetap, an investigational oral therapy for neurodeg
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Fortress Biotech (FBIO) Q3 Revenue Rose 9% To $19.2M
Fortress Biotech reported Q3 2026 net revenue of $19.2M, up approximately 9% from Q3 2025, and said it repaid its credit facility in full in September 2026. Top-line data from the Phase 2 FB-607 study is expected in the
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
PDS Biotechnology Corporation (PDSB) Reports $7.6M Q3 Net Loss
PDS Biotechnology Corporation reported a Q3 2026 net loss of $7.6M, or $0.11 per share, versus $9.0M, or $0.19 per share, in Q3 2025. Cash and cash equivalents were $15.2M at September 30, 2026.Material DetailsContext by
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update
HAYWARD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. NASDAQ:BNTC (“Benitec” or the “Company”), a clinical-stage biotechnology company developing disease-modifying genetic medicines for life-threateni
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Benitec Biopharma Q1 FY27 net loss widens 44% year over year to $12.93 million
Benitec Biopharma Q1 FY27 net loss widens 44% year over year to $12.93 million Benitec Biopharma
EQUITY | Nov 13, 2026, 01:02 PM UTC
L
Food Inflation Reaches 8.9%; ICICI Bank Sees Possible RBI Hikes
ICICI Bank expects inflation to remain elevated over the next few quarters before easing in the second half of FY28. The report says food inflation could raise the possibility of RBI tightening.
RATES | Nov 13, 2026, 01:02 PM UTC
L
Vislink Technologies, Inc. (VISL) Q3 Revenue Rose 19.8% YoY to $4.6M
Q3 revenue rose 19.8% year over year to $4.6M but fell 22.2% sequentially. Nine-month revenue increased 19.7% to $15.8M, and the non-GAAP EBITDA loss narrowed to $0.2M from $6.0M.Material DetailsContext by AI AnalystThe
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth
WOBURN, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc.
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
Vislink Reports Third Quarter 2026 Financial Results
MT. OLIVE, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) OTCID:VISL, a global technology leader in the capture, delivery, and management of high-quality live video and as
EQUITY | Nov 13, 2026, 01:02 PM UTC
H
Sensex, Nifty Fall As Crude Oil And Inflation Pressures Weigh On Markets
Indian equity benchmarks declined on Friday as elevated crude oil prices and rising inflation concerns weighed on investor sentiment, trimming their weekly gains despite sustained foreign institutional inflows.The Nifty
MACRO | Nov 13, 2026, 01:02 PM UTC
L
Moving iMage Technologies (MITQ) Reports $181K Q1 Net Income, Expects ~$5.4M Q2 Revenue
Moving iMage Technologies reported Q1 fiscal 2027 net income of $181K, or $0.02 per share, on a 9.2% revenue increase to $6.1M. It expects approximately $5.4M revenue in Q2, citing seasonal softness.Material DetailsConte
EARNINGS | Nov 13, 2026, 01:02 PM UTC
L
ProVen VCT Proposes Merger and Subscription Offer
ProVen VCT plc and ProVen Growth and Income VCT plc outline proposals for a merger and a ProVen VCT offer for subscription.
MNA | Nov 13, 2026, 01:02 PM UTC
M
Canlan Ice Sports Reports 8% Q3 Revenue Growth
Canlan Ice Sports said Q3 2026 revenue grew 8% year over year and profitability improved, without providing revenue or earnings figures. It declared a quarterly dividend of $0.04, up from $0.03.
EQUITY | Nov 13, 2026, 01:01 PM UTC
M
Bitcoin Falls 5% to $69,227, Below $70,000 for First Time Since August
Bitcoin traded at $69,227 at 11:53 GMT on Friday, down 5% from the same time Thursday. Forced selling in leveraged trades intensified the decline, which the report links to US inflation fears and ETF withdrawals.
CRYPTO | Nov 13, 2026, 01:01 PM UTC
L
BRIEF-Vislink Technologies Q3 Gross Margin 58.7%
Nov 13 (Reuters) - Vislink Technologies Q3 revenue USD 4.6 million.
EARNINGS | Nov 13, 2026, 01:01 PM UTC
L
JPMorgan cuts Hemnet target price to SEK 74 from SEK 90
EQUITY | Nov 13, 2026, 01:01 PM UTC
L
Suncrete 3Q Adjusted EBITDA $22.4M >RMIX
Suncrete 3Q Adjusted EBITDA $22.4M >RMIX
EQUITY | Nov 13, 2026, 01:01 PM UTC
L
BRIEF-Bragg Gaming Q3 Revenue EUR 20.6 Million
BRIEF-Bragg Gaming Q3 Revenue EUR 20.6 Million Nov 13 (Reuters) - Bragg Gaming Q3 gross margin 56%.
EARNINGS | Nov 13, 2026, 01:01 PM UTC
L
BRIEF-Owlet Q3 Adjusted EPS USD 0.11
BRIEF-Owlet Q3 Adjusted EPS USD 0.11 Nov 13 (Reuters) - Owlet Q3 revenue USD 30.4 million vs. IBES e
EARNINGS | Nov 13, 2026, 01:01 PM UTC
L
Eagle Point Income reports Q3 2026 GAAP net income of $4.6 million
Eagle Point Income reports Q3 2026 GAAP net income of $4.6 million Eagle Point Income reported t
EQUITY | Nov 13, 2026, 01:01 PM UTC
L
BRIEF-Vislink Technologies Q3 Gross Margin 58.7%
BRIEF-Vislink Technologies Q3 Gross Margin 58.7% Nov 13 (Reuters) - Vislink Technologies Q3 revenue
EARNINGS | Nov 13, 2026, 01:01 PM UTC
L
Barclays initiates Ultra Clean at Equal-Weight
Benzinga reports Barclays initiated coverage of Ultra Clean at Equal-Weight. The headline also states a $65.00-per-share price target.
EQUITY | Nov 13, 2026, 01:01 PM UTC
L
Revvity Targets Above-Market Growth Through Organizational Simplification
Revvity said it targets above-market growth through organizational simplification.
EQUITY | Nov 13, 2026, 01:01 PM UTC
L
Revvity Hosts Investor Day to Outline Strategy
Revvity is hosting an Investor Day to outline its strategy and long-term outlook.
EQUITY | Nov 13, 2026, 01:01 PM UTC